New York · 2025 Regular Session · Bill
S 1816: Relates to the definition of blood lead levels
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 1816 is a bill introduced in the New York Senate on January 14, 2025. According to its official title, it concerns: Relates to the definition of blood lead levels. Primary sponsor: Nathalia Fernández (Democratic). It lists 2 additional sponsors. Most recent recorded action (March 23, 2026): REFERRED TO WAYS AND MEANS.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Relates to the definition of elevated blood lead levels; provides that elevated lead levels means a blood lead level greater than or equal to 3.5 micrograms of lead per deciliter of whole blood or such lower blood lead level as may be established by the department of health pursuant to rule or regulation.
Sponsors
Sponsors by party (alphabetical): Democratic 2 · Democratic/Working Families 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Nathalia Fernández | Primary sponsor | Democratic | Senate | 34 |
| Brian Kavanagh | Co-sponsor | Democratic | Senate | 27 |
| Lea Webb | Co-sponsor | Democratic/Working Families | Senate | 52 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO WAYS AND MEANS
- DELIVERED TO ASSEMBLY
- PASSED SENATE
- ADVANCED TO THIRD READING
- 2ND REPORT CAL.
- 1ST REPORT CAL.555
- REFERRED TO HEALTH
- RETURNED TO SENATE
- DIED IN ASSEMBLY
- REFERRED TO WAYS AND MEANS
- DELIVERED TO ASSEMBLY
- PASSED SENATE
Showing 12 most recent of 16 actions. Full history